Aviva Swiss

GHRP-6 is a synthetic met-enkephalin analogue and growth hormone releasing peptide. GHRP-6 contains 6 amino acids including unnatural D-amino acids to facilitate growth hormone release (secretagogue).

GHRP-2 is a growth hormone releasing polypeptide with short half-life. GHRP-2 consists of 6 amino acids. GHRP-2, a hexapeptide tend to influence G-protein coupled receptors.

Frag 176-191 is a modified amino acid sequence of growth hormone. The lipolytic activity of Frag 176-191 was confirmed by several published studies. The compound acts directly on the adipose fat tissues, increasing lipolysis and decreasing lipogenesis.

Melanotan 2 (MT-2) is a man-made version of alpha melanocyte stimulating hormone (MSH), a melanocortin peptide hormone.

IGF1 LR3 (Long R3 Insulin-like Growth Factor) is a polypeptide hormone with properties similar to insulin. However, LR3 is a modified form of IGF1 to increase half-life and to prevent deactivation due to protein binding.

IGF1-DES (Insulin Growth Factor – 1 DES) is a human recombinant analogue of somatomedin- C with insulin-like properties. IGF1-DES contains 67 amino acids chain that mimics insulin structure.

CJC-1295, a modified form of GRF 1-29 NO DAC, is a peptide hormone that contains 29 amino acids. Since the 2000’s, the compound has been studied to explore the lipolytic properties, particularly the visceral fat elimination.

CJC-1295 (DAC) belongs to tetra-substituted peptide hormones classification. CJC-1295 (DAC) contains 30 amino acids. The modified version of GRF 1-29 demonstrates a high affinity towards GHRH receptors.